Real-world decision-making in the management of patients presenting with major bleeding on rivaroxaban: the Auckland regional experience.

Grainger, Brian T; Merriman, Eileen; Royle, Gordon; Eaddy, Nicola; Ockelford, Paul; Young, Laura

Grainger, Brian T; Merriman, Eileen; Royle, Gordon; Eaddy, Nicola; Ockelford, Paul; Young, Laura.

Afiliación

Grainger BT; Department of Haematology, Auckland City Hospital, Auckland, New Zealand.
Merriman E; Department of Haematology, North Shore Hospital, Auckland, New Zealand.
Royle G; Department of Haematology, Middlemore Hospital, Auckland, New Zealand.
Eaddy N; Department of Haematology, Auckland City Hospital, Auckland, New Zealand.
Ockelford P; Department of Haematology, Auckland City Hospital, Auckland, New Zealand.
Young L; Department of Haematology, Auckland City Hospital, Auckland, New Zealand.

Intern Med J ; 53(8): 1444-1449, 2023 08.

Article en En | MEDLINE | ID: mdl-35467774

Asunto(s)

Rivaroxabán; Ácido Tranexámico; Humanos; Rivaroxabán/efectos adversos; Estudios Retrospectivos; Hemorragia/tratamiento farmacológico; Anticoagulantes/efectos adversos; Ácido Tranexámico/uso terapéutico

Palabras clave

anticoagulant; major bleeding; rivaroxaban

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ácido Tranexámico / Rivaroxabán Tipo de estudio: Guideline / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Intern Med J Asunto de la revista: MEDICINA INTERNA Año: 2023 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google